Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.

@article{PerezIglesias2014CourseOW,
  title={Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.},
  author={Roc{\'i}o Perez-Iglesias and Obdulia Mart{\'i}nez-Garc{\'i}a and Gema Pardo-Garc{\'i}a and Jos{\'e} Antonio Amado and Mar{\'i}a Teresa Garc{\'i}a-Unzueta and Rafael Tabar{\'e}s-Seisdedos and Benedicto Crespo-Facorro},
  journal={The international journal of neuropsychopharmacology},
  year={2014},
  volume={17 1},
  pages={41-51}
}
Data on the long-term metabolic side-effects associated with antipsychotics are scarce. Prospective longitudinal studies in medication-naive patients with a first episode of psychosis are a valuable source of information as they provide an assessment prior to the antipsychotic exposure and minimize the effect of potential confounding factors. The aim of this study was to assess the course of weight gain and the incidence of metabolic abnormalities during the first 3 yr of antipsychotic… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…